https://www.statnews.com/2023/10/30/sareptas-duchenne-gene-therapy-fails-to-meet-primary-endpoint-in-pivotal-trial/
0
0
10/30/23 at 8:36pm
Organization
STAT
41 words
0
Comments
Sarepta Therapeutics said Monday afternoon that its gene therapy for Duchenne muscular dystrophy failed to improve muscle function compared to a placebo in a large clinical trial.
You are the first to view
Create an account
or login to join the discussion